16 results
-
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,17-19 March 2008
CHMP, Last updated: 20/03/200818 years of age. Zevalin (ibritumomab tiuxetan), from Schering AG, to extend … -
List item
National expert: Daniele Focosi, European Medicines Agency (updated)
- Declaration of interests - 78.91 KB | PDF
- Curriculum Vitae - 201.79 KB | PDF
-
List item
National expert: Mats Jerkeman, European Medicines Agency (updated)
- Declaration of interests - 80.84 KB | PDF
- Curriculum Vitae - 110.2 KB | PDF
-
List item
National expert: Jose Maria Moraleda, European Medicines Agency (updated)
- Declaration of interests - 85.76 KB | PDF
- Curriculum Vitae - 179.46 KB | PDF
-
List item
National expert: Francesco d'Amore, European Medicines Agency (updated)
- Declaration of interests - 82.12 KB | PDF
- Curriculum Vitae - 139.52 KB | PDF
-
List item
Press release: European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products 23-25 November 2003
Last updated: 25/09/2003application for Zevalin (ibritumomab tiuxetan), from Schering AG, which is … -
List item
Class waivers
Last updated: 28/05/2018 -
List item
Press release: Stimulating the development of medicines for children
Last updated: 23/07/2015 -
List item
Needs for paediatric medicines
Last updated: 11/05/2016 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013 -
List item
News: Feedback requested on the draft list of EU reference dates for periodic safety update reports in preparation for introduction of the new pharmacovigilance legislation
Last updated: 04/04/2012 -
List item
PRAC: meeting archive 2014-2015
Last updated: 13/05/2016 -
List item
PRAC: Agendas, minutes and highlights
Last updated: 14/06/2019 -
List item
COMP: Agendas, minutes and meeting reports
Last updated: 15/06/2020 -
List item
Annual reports and work programmes
Last updated: 15/06/2020 -
List item
CHMP: meeting archive 2016-2018
Last updated: 26/02/2020